HK Stock MarketDetailed Quotes

01244 3D MEDICINES

Watchlist
  • 5.560
  • -0.010-0.18%
Market Closed Apr 19 16:08 CST
1.44BMarket Cap-2479P/E (TTM)

3D MEDICINES Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q6)Jun 30, 2023
(FY)Dec 31, 2022
(Q6)Jun 30, 2022
(FY)Dec 31, 2021
(FY)Dec 31, 2020
(FY)Dec 31, 2019
Cash flow from operating activities
Earning before tax
41.21%-190.2M
28.03%-1.05B
---323.55M
-130.07%-1.46B
-98.29%-635.38M
---320.43M
Profit adjustment
Interest (income) - adjustment
-10.41%-2.82M
-31.04%-7.21M
---2.56M
-241.74%-5.5M
-1,025.87%-1.61M
---143K
Investment loss (gain)
-957.07%-6.06M
-350.24%-1.91M
---573K
-171.79%-424K
-609.09%-156K
---22K
Impairment and provisions:
174.26%277K
803.85%1.18M
--101K
--130K
--0
--0
-Other impairments and provisions
174.26%277K
803.85%1.18M
--101K
--130K
----
----
Revaluation surplus:
-101.27%-1.83M
-31.17%657M
--143.5M
199.02%954.56M
24,102.58%319.23M
--1.32M
-Other fair value changes
-101.27%-1.83M
-31.17%657M
--143.5M
199.02%954.56M
24,102.58%319.23M
--1.32M
Asset sale loss (gain):
--0
--0
--0
47,850.00%959K
-33.33%2K
--3K
-Loss (gain) on sale of property, machinery and equipment
----
----
----
47,850.00%959K
-33.33%2K
--3K
Depreciation and amortization:
31.86%14.35M
71.55%21.6M
--10.88M
273.51%12.59M
44.49%3.37M
--2.33M
-Depreciation
32.01%14.3M
71.90%21.5M
--10.83M
271.02%12.51M
44.49%3.37M
--2.33M
-Amortization of intangible assets
0.00%51K
20.24%101K
--51K
--84K
----
----
Financial expense
329.19%4.04M
103.73%3.11M
--942K
-81.04%1.53M
-47.01%8.06M
--15.21M
Exchange Loss (gain)
62.23%-8.18M
-1,042.42%-34.86M
---21.65M
-37.59%3.7M
908.59%5.93M
---733K
Special items
70.51%108.75M
-9.80%141.69M
--63.78M
37,659.62%157.08M
-98.40%416K
--26.07M
Operating profit before the change of operating capital
36.76%-81.66M
19.51%-271.43M
---129.13M
-12.35%-337.2M
-8.59%-300.14M
---276.4M
Change of operating capital
Inventory (increase) decrease
-310.36%-6.65M
-9,000.00%-1.18M
---1.62M
---13K
----
----
Accounts receivable (increase)decrease
-25.62%-54.91M
79.83%-13.06M
---43.71M
-21,705.39%-64.76M
-371.43%-297K
---63K
Accounts payable increase (decrease)
-121.52%-16.1M
184.65%96.52M
--74.83M
870.44%33.91M
-109.61%-4.4M
--45.79M
prepayments (increase)decrease
-345.32%-6.16M
-2,478.18%-101.04M
--2.51M
-122.73%-3.92M
1,775.70%17.24M
---1.03M
Cash  from business operations
-70.39%-165.48M
21.99%-290.2M
---97.12M
-29.34%-371.99M
-24.12%-287.6M
---231.71M
Special items of business
-122.79%-2.64M
324.19%11.42M
--11.57M
-154.95%-5.09M
196.57%9.27M
---9.6M
Net cash from operations
-96.51%-168.12M
26.07%-278.78M
---85.55M
-35.48%-377.08M
-15.34%-278.33M
---241.3M
Cash flow from investment activities
Interest received - investment
66.49%5.39M
28.93%7.07M
--3.24M
240.50%5.48M
1,025.87%1.61M
--143K
Loan receivable (increase) decrease
----
77.34%-997K
----
---4.4M
--0
----
Decrease in deposits (increase)
----
--0
---201.34M
200.00%6M
---6M
----
Sale of fixed assets
----
----
----
----
--4K
----
Purchase of fixed assets
69.03%-5.57M
-23.04%-53.98M
---17.99M
-293.58%-43.87M
-21,336.54%-11.15M
---52K
Purchase of intangible assets
----
----
----
---12.51M
----
----
Acquisition of subsidiaries
----
----
----
----
---11.12M
----
Recovery of cash from investments
51.52%151.52M
427.08%265.77M
--100M
717.11%50.42M
-69.18%6.17M
--20.02M
Cash on investment
-76.06%-176.06M
-359.97%-459.97M
---100M
---100M
----
---6M
Net cash from investment operations
88.56%-24.73M
-144.87%-242.11M
---216.1M
-382.77%-98.87M
-245.11%-20.48M
--14.11M
Net cash before financing
36.07%-192.84M
-9.44%-520.89M
---301.65M
-59.28%-475.95M
-31.52%-298.81M
---227.19M
Cash flow from financing activities
New borrowing
607.08%127.6M
--149.04M
--18.05M
----
-98.45%3.52M
--227.95M
Refund
---52.49M
-443.41%-19.14M
----
97.43%-3.52M
58.97%-136.9M
---333.65M
Issuing shares
--8.99M
-80.58%313.52M
----
105.97%1.61B
98.27%783.82M
--395.34M
Interest paid - financing
-316.38%-3.86M
-25.00%-1.91M
---928K
91.29%-1.53M
-144.36%-17.53M
---7.18M
Absorb investment income
----
----
----
--332.78M
----
----
Issuance expenses and redemption of securities expenses
21.88%-846K
97.92%-22.59M
---1.08M
-3,423.90%-1.09B
---30.84M
----
Other items of the financing business
36.43%-3.11M
30.59%-10.51M
---4.89M
-384.27%-15.15M
424.68%5.33M
---1.64M
Net cash from financing operations
584.39%76.28M
-51.38%408.41M
--11.15M
38.31%840.08M
116.29%607.39M
--280.82M
Effect of rate
-83.81%3.61M
954.07%34.91M
--22.32M
36.86%-4.09M
-794.53%-6.47M
--932K
Net Cash
59.88%-116.56M
-130.89%-112.47M
---290.5M
18.00%364.13M
475.38%308.58M
--53.63M
Begining period cash
-10.02%696.74M
86.91%774.31M
--774.31M
269.36%414.26M
94.74%112.16M
--57.59M
Cash at the end
15.35%583.79M
-10.02%696.74M
--506.12M
86.91%774.31M
269.36%414.26M
--112.16M
Cash balance analysis
Cash and cash equivalent balance
--0
--0
--0
--0
--0
--0
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
IAS
IAS
IAS
IAS
IAS
IAS
Audit Opinions
--
Unqualified Opinion
--
Unqualified Opinion
Unqualified Opinion
Unqualified Opinion
Auditor
--
Ernst & Young
--
Ernst & Young
Ernst & Young
Ernst & Young
(Q6)Jun 30, 2023(FY)Dec 31, 2022(Q6)Jun 30, 2022(FY)Dec 31, 2021(FY)Dec 31, 2020(FY)Dec 31, 2019
Cash flow from operating activities
Earning before tax 41.21%-190.2M28.03%-1.05B---323.55M-130.07%-1.46B-98.29%-635.38M---320.43M
Profit adjustment
Interest (income) - adjustment -10.41%-2.82M-31.04%-7.21M---2.56M-241.74%-5.5M-1,025.87%-1.61M---143K
Investment loss (gain) -957.07%-6.06M-350.24%-1.91M---573K-171.79%-424K-609.09%-156K---22K
Impairment and provisions: 174.26%277K803.85%1.18M--101K--130K--0--0
-Other impairments and provisions 174.26%277K803.85%1.18M--101K--130K--------
Revaluation surplus: -101.27%-1.83M-31.17%657M--143.5M199.02%954.56M24,102.58%319.23M--1.32M
-Other fair value changes -101.27%-1.83M-31.17%657M--143.5M199.02%954.56M24,102.58%319.23M--1.32M
Asset sale loss (gain): --0--0--047,850.00%959K-33.33%2K--3K
-Loss (gain) on sale of property, machinery and equipment ------------47,850.00%959K-33.33%2K--3K
Depreciation and amortization: 31.86%14.35M71.55%21.6M--10.88M273.51%12.59M44.49%3.37M--2.33M
-Depreciation 32.01%14.3M71.90%21.5M--10.83M271.02%12.51M44.49%3.37M--2.33M
-Amortization of intangible assets 0.00%51K20.24%101K--51K--84K--------
Financial expense 329.19%4.04M103.73%3.11M--942K-81.04%1.53M-47.01%8.06M--15.21M
Exchange Loss (gain) 62.23%-8.18M-1,042.42%-34.86M---21.65M-37.59%3.7M908.59%5.93M---733K
Special items 70.51%108.75M-9.80%141.69M--63.78M37,659.62%157.08M-98.40%416K--26.07M
Operating profit before the change of operating capital 36.76%-81.66M19.51%-271.43M---129.13M-12.35%-337.2M-8.59%-300.14M---276.4M
Change of operating capital
Inventory (increase) decrease -310.36%-6.65M-9,000.00%-1.18M---1.62M---13K--------
Accounts receivable (increase)decrease -25.62%-54.91M79.83%-13.06M---43.71M-21,705.39%-64.76M-371.43%-297K---63K
Accounts payable increase (decrease) -121.52%-16.1M184.65%96.52M--74.83M870.44%33.91M-109.61%-4.4M--45.79M
prepayments (increase)decrease -345.32%-6.16M-2,478.18%-101.04M--2.51M-122.73%-3.92M1,775.70%17.24M---1.03M
Cash  from business operations -70.39%-165.48M21.99%-290.2M---97.12M-29.34%-371.99M-24.12%-287.6M---231.71M
Special items of business -122.79%-2.64M324.19%11.42M--11.57M-154.95%-5.09M196.57%9.27M---9.6M
Net cash from operations -96.51%-168.12M26.07%-278.78M---85.55M-35.48%-377.08M-15.34%-278.33M---241.3M
Cash flow from investment activities
Interest received - investment 66.49%5.39M28.93%7.07M--3.24M240.50%5.48M1,025.87%1.61M--143K
Loan receivable (increase) decrease ----77.34%-997K-------4.4M--0----
Decrease in deposits (increase) ------0---201.34M200.00%6M---6M----
Sale of fixed assets ------------------4K----
Purchase of fixed assets 69.03%-5.57M-23.04%-53.98M---17.99M-293.58%-43.87M-21,336.54%-11.15M---52K
Purchase of intangible assets ---------------12.51M--------
Acquisition of subsidiaries -------------------11.12M----
Recovery of cash from investments 51.52%151.52M427.08%265.77M--100M717.11%50.42M-69.18%6.17M--20.02M
Cash on investment -76.06%-176.06M-359.97%-459.97M---100M---100M-------6M
Net cash from investment operations 88.56%-24.73M-144.87%-242.11M---216.1M-382.77%-98.87M-245.11%-20.48M--14.11M
Net cash before financing 36.07%-192.84M-9.44%-520.89M---301.65M-59.28%-475.95M-31.52%-298.81M---227.19M
Cash flow from financing activities
New borrowing 607.08%127.6M--149.04M--18.05M-----98.45%3.52M--227.95M
Refund ---52.49M-443.41%-19.14M----97.43%-3.52M58.97%-136.9M---333.65M
Issuing shares --8.99M-80.58%313.52M----105.97%1.61B98.27%783.82M--395.34M
Interest paid - financing -316.38%-3.86M-25.00%-1.91M---928K91.29%-1.53M-144.36%-17.53M---7.18M
Absorb investment income --------------332.78M--------
Issuance expenses and redemption of securities expenses 21.88%-846K97.92%-22.59M---1.08M-3,423.90%-1.09B---30.84M----
Other items of the financing business 36.43%-3.11M30.59%-10.51M---4.89M-384.27%-15.15M424.68%5.33M---1.64M
Net cash from financing operations 584.39%76.28M-51.38%408.41M--11.15M38.31%840.08M116.29%607.39M--280.82M
Effect of rate -83.81%3.61M954.07%34.91M--22.32M36.86%-4.09M-794.53%-6.47M--932K
Net Cash 59.88%-116.56M-130.89%-112.47M---290.5M18.00%364.13M475.38%308.58M--53.63M
Begining period cash -10.02%696.74M86.91%774.31M--774.31M269.36%414.26M94.74%112.16M--57.59M
Cash at the end 15.35%583.79M-10.02%696.74M--506.12M86.91%774.31M269.36%414.26M--112.16M
Cash balance analysis
Cash and cash equivalent balance --0--0--0--0--0--0
Currency Unit CNYCNYCNYCNYCNYCNY
Accounting Standards IASIASIASIASIASIAS
Audit Opinions --Unqualified Opinion--Unqualified OpinionUnqualified OpinionUnqualified Opinion
Auditor --Ernst & Young--Ernst & YoungErnst & YoungErnst & Young

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
HK
Overall
Symbol
Latest Price
%Chg